Navigation Links
Text focuses on diagnosing infections in immunocompromised patients
Date:10/9/2008

Over the past twenty-five years, the number of patients with compromised immune systems has grown astronomically. High-risk patients such as these require a unique set of healthcare solutions that take into consideration everything from the etiology and degree of immune suppression to the individual patient's nutritional status. A new text from ASM Press, Diagnostic Microbiology of the Immunocompromised Host, examines a wide range of approaches and challenges to infectious disease diagnostics for immunocompromised patients.

"Certainly there are books containing information on clinical testing; however, no standard laboratory reference focuses heavily on issues unique to the immunocompromised population. It is the goal of the authors to consolidate such discussions in a single, easily referenced text that can be used by clinical healthcare providers and laboratory professionals alike," says co-editor Randall T. Hayden of St. Jude's Children's Research Hospital. Other editors include Karen C. Carroll, The Johns Hopkins University School of Medicine; Yi-Wei Tang, Vanderbilt University Medical Center and Donna M. Wolk, University of Arizona College of Medicine.

Divided into four sections, the book takes a multifaceted approach to the detection and characterization of infections encountered in this high-risk patient group. The first section provides a broad explanation of the causes of immune suppression, the populations at risk for infections, and the various kinds of infections. The next section addresses crucial laboratory diagnostic methods for individual pathogens, while the third section takes a more systematic perspective on the affected organs in immunocompromised patients. The volume concludes with a discussion of future trends in the field. The material is clearly summarized in practical, user-friendly procedures that can be applied to everyday patient care challenges.

"We hope this book will fill a void in many health care
'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. New lab manual focuses on essential methods for purifying and characterizing proteins
2. Project focuses on production of hydrogen from bacteria and sunlight
3. Publication offers labs consensus recommendations for diagnosing parasitic diseases
4. Hidden infections crucial to understanding, controlling disease outbreaks
5. Antimicrobial sutures reduce infections in brain shunt surgery, study finds
6. CMV infections affect more than just patients with compromised immune systems, researchers find
7. Analysis of RNA role in spreading disease advances study of damaging plant infections
8. Bacterial infections in premature babies more common than previously realized
9. New drug targets may fight tuberculosis and other bacterial infections in novel way
10. Bacteria that cause urinary tract infections invade bladder cells
11. Best treatment identified to reduce deadly Staph infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2012)... Athens, Ga. The rate at which the rabies ... ecological traits of its hosts, according to researchers at ... Control and Prevention and Katholieke Universiteit Leuven in Belgium. ... PLoS Pathogens , found that the host,s geographical location ... of evolution. Rabies viruses in tropical and sub-tropical bat ...
(Date:5/18/2012)... everyday life, we use gasoline, diesel, plastics, rubbers, ... oil through petrochemical refinery processes. However, this is ... fossil resources. Furthermore, our world is facing problems ... due to the increasing use of fossil resources. ... use of renewable non-food biomass for the production ...
(Date:5/18/2012)... the winners of their 6th Annual Research Awards ... the very best research that has been made ... guests attended the prestigious ceremony including leading researchers, ... world. , The winners were selected by ... journals which published more than 18,000 peer-reviewed open ...
Breaking Biology News(10 mins):Hitting snooze on the molecular clock: Rabies evolves slower in hibernating bats 2Hitting snooze on the molecular clock: Rabies evolves slower in hibernating bats 3Production of chemicals without petroleum 2BioMed Central announces winners of 6th Annual Research Awards 2Pharmacists Offer Guidance on Top Over The Counter Medications 16616 1Pharmacists Offer Guidance on Top Over The Counter Medications 16616 2Pharmacists Offer Guidance on Top Over The Counter Medications 16616 3Researchers report widespread use of medications among pregnant women 81301 1Researchers report widespread use of medications among pregnant women 81301 2Rice born detector finds heaviest antimatter 18956 1Rice born detector finds heaviest antimatter 18956 2Rice born detector finds heaviest antimatter 18956 3
... Metabolic syndrome, a collection of related abnormalities like ... a major risk for developing heart disease and ... cholesterol (familial hyperlipidemia or FH) can be especially ... found that blocking the enzyme stearoyl-CoA desaturase-1 (SCD1), ...
... bioengineer Jennifer West is being recognized today with one ... O,Donnell Award from The Academy of Medicine, Engineering and ... for excellence in medical, scientific and engineering research, include ... West, a pioneer in the field of biomaterials engineering, ...
... the Stanford University Program in Biodesign have released ... requirements of medical device regulation in the United ... 2007 issue of the Journal of Medical Devices, ... versus pharmaceuticals and underscores the complexity of the ...
Other Biology News:Rice's West honored as one of Texas' best researchers 2Rice's West honored as one of Texas' best researchers 3Stanford researchers publish review of US medical device regulation 2Stanford researchers publish review of US medical device regulation 3
(Date:5/16/2012)... Calif., May 16, 2012  Questcor Pharmaceuticals, Inc. ... its Board of Directors has increased the Company,s ... 5 million shares. Since the beginning ... to shareholders through the repurchase of approximately 19.2 ... of its shares as of the commencement of ...
(Date:5/15/2012)... Journal of Visualized Experiments ) will publish two articles ... Reduction Agency (DTRA). JoVE is proud ... Schafmeister and State University of New York Buffalo,s Dr. ... support of scientists conducting research for DTRA has significant ... defense threats. DTRA exists to safeguard America and its ...
(Date:5/15/2012)... May 15, 2012  OrbusNeich today announced that 12-month ... and safety outcomes involving the use of the company,s ... ® Liberte ® paclitaxel-eluting stent. The data ... I at the Lukaskrankenhaus in Neuss, Germany, at EuroPCR ... set, the clinically driven target lesion failure (TLF) rate ...
(Date:5/15/2012)... Generex Biotechnology Corporation (OTCBB: GNBT), in anticipation ... trials, is pleased to announce today that the expertise ... subsidiary, Antigen Express, Inc., has been expanded by the ... research and immuno-therapeutic treatments of breast cancer: ... University School of Medicine Melvin and Bren ...
Breaking Biology Technology:Questcor Pharmaceuticals Expands Repurchase Program 2Questcor Pharmaceuticals Expands Repurchase Program 3Questcor Pharmaceuticals Expands Repurchase Program 4Questcor Pharmaceuticals Expands Repurchase Program 5JoVE partners with US government to publish cutting-edge defense research 2OrbusNeich's Combo Dual Therapy Stent™ Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up 2OrbusNeich's Combo Dual Therapy Stent™ Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up 3OrbusNeich's Combo Dual Therapy Stent™ Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up 4Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers 2Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers 3Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers 4
... 8 /Xinhua-PRNewswire-FirstCall/ --,China Biologic Products, Inc. (OTC Bulletin ... the leading plasma-based pharmaceutical companies,in the People,s Republic ... present at the upcoming SIG Second Annual Beijing ... the Grand Hyatt Beijing Hotel in Beijing., ...
... 4 weeks of treatment with R7128 1500mg BID with Pegasys(R) plus ... Copegus(R) -, - Safety and ... ... Inc.,(Nasdaq: VRUS ) announces the preliminary results of the fourth cohort of a,4-week Phase ...
... and DUBLIN, Ireland, Sept. 8 /PRNewswire-FirstCall/,-- Concuity, ... TTPA ) and a leading,provider of contract ... HFMA") and services, today announced that Valley ... Compliance suite to more,accurately calculate payments from ...
Other Biology Technology:China Biologic Products to Present at the SIG Beijing Management Summit 2China Biologic Products to Present at the SIG Beijing Management Summit 3Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 2Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 3Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 4Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 5Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 6Valley Baptist Health System Selects Concuity's ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers 2Valley Baptist Health System Selects Concuity's ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers 3Valley Baptist Health System Selects Concuity's ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers 4